In our study we show increased transcriptional and post-transcriptional expression of survivin in pulmonary arteries and lungs of patients with PAH and also in two validated experimental models of PAH (Blanco et al., 2017; Bueno-Beti et al., 2018). This evidence concerns the gene BIRC5 and pulmonary arterial hypertension.